A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5434
Abstract: Monitoring for substandard medicines by regulatory agencies is a key post‐market surveillance activity. It is important to prioritise critical product defects for review to ensure that prompt risk mitigation actions are taken. read more here.
Keywords: risk classification; substandard; classification model; prioritising management ... See more keywords
Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports
Sign Up to like & getrecommendations! Published in 2017 at "Drug Safety"
DOI: 10.1007/s40264-016-0499-5
Abstract: IntroductionThe distribution and use of substandard medicines (SSMs) is a public health concern worldwide. The detection of SSMs is currently limited to expensive large-scale assay techniques such as high-performance liquid chromatography (HPLC). Since 2013, the… read more here.
Keywords: substandard medicines; individual case; disproportionality analysis; analysis ... See more keywords
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
Sign Up to like & getrecommendations! Published in 2020 at "BMC Public Health"
DOI: 10.1186/s12889-020-08897-x
Abstract: Background High prevalence of falsified, counterfeit and substandard medicines pose a threat to public health and treatment failure. This study aimed to investigate the quality of selected essential medicines available in Mongolia. Methods A cross-sectional… read more here.
Keywords: substandard medicines; cross sectional; analysis; essential medicines ... See more keywords